Advertisement
St. Jude Medical
Subscribe to St. Jude Medical

The Lead

Patient Monitoring Market Nears 30 Billion

October 7, 2014 9:05 am | by Kalorama Information | News | Comments

The global advanced patient monitoring market is currently worth about $29.7 billion, up 7% from last year, according to Kalorama Information. The market research firm specializing in diagnostics and medical devices says that the industry...

MDPC Publishes Robust Security Risk Assessment Framework for Medical Devices

September 26, 2014 10:56 am | by Medical Device Privacy Consortium | News | Comments

The Medical Device Privacy Consortium's Product Security Working Group has developed a robust...

CE Mark Grants St. Jude’s Pacing Lead Expanded Patient Access to MRI Scans

September 22, 2014 9:31 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, has announced CE Mark approval of...

St. Jude Medical Announces Launch of OPTIS Integrated System

September 15, 2014 9:38 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the company has secured...

View Sample

FREE Email Newsletter

Pacemaker Monitor Teardown

September 2, 2014 2:12 pm | by David L. Jones, EEVblog | Videos | Comments

What's inside a dial-in pacemaker monitor system? That’s what this installment of EEVblog seeks to discover. David L. Jones is an electronics design engineer based in Sydney, Australia. He hosts the EEVblog, the world’s largest and most popular engineering...

Heart Hospital to Implant Portico Transcatheter Aortic Valve System as Part of Clinical Trial

August 28, 2014 9:27 am | by PR Newswire | News | Comments

On Aug. 26, 2014, physicians at Heart Hospital of Austin became the first in Texas to implant the new Portico Re-sheathable Transcatheter Aortic Valve System—an innovative, repositionable aortic heart valve and delivery system. Heart Hospital...

St. Jude Medical Resolves FDA Warning Letter for Plano Facility

August 27, 2014 9:22 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, has announced that it has been notified by the U.S. Food and Drug Administration (FDA) that issues cited in the Plano, Texas, facility’s warning letter have been addressed. “We’re...

Advertisement

St. Jude Medical Completes Acquisition of NeuroTherm

August 7, 2014 9:21 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced it has completed its acquisition of privately held NeuroTherm, Inc., a manufacturer of interventional pain management therapies. “Over the last year, we have launched...

Occlutech Wins Invalidation of St Jude Patent

July 23, 2014 9:53 am | by PR Newswire | News | Comments

Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, has announced that it has successfully obtained a ruling by the U.K. Patents Court in the High Court of Justice in London, that...

CE Mark Approval and First Use of St. Jude's FlexAbility Ablation Catheter

July 22, 2014 8:59 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval and first use of the FlexAbility Ablation Catheter, a novel ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias...

St. Jude Medical Announces Definitive Agreement to Acquire NeuroTherm

July 14, 2014 9:24 am | by Business Wire | News | Comments

St. Jude Medical, a global medical device company, today announced that it has signed a definitive agreement to acquire privately held NeuroTherm, Inc., a manufacturer of interventional pain management therapies, for approximately $200 million...

St. Jude Medical Resolves FDA Warning Letter for Sylmar Facility

July 2, 2014 9:14 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, announced that it has been notified by the U.S. Food and Drug Administration (FDA) that issues cited in the Sylmar, Calif., facility’s warning letter have been addressed. “We take...

Advertisement

First Alabamian Receives New Retrievable, Nonsurgical Pacemaker

June 23, 2014 8:53 am | by University of Alabama at Birmingham | News | Comments

Hoover resident Jack Brymer was driving home with his wife, Shirley, one night recently when it became clear to him his health problem was getting worse at a rapid pace. “I had been having dizzy spells, and it would feel like I was going...

St. Jude’s Leadless Pacemaker Receives Prestigious Innovation Award

June 18, 2014 4:03 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical Inc., a global medical device company, today announced the Nanostim leadless pacemaker was awarded the 2014 Innovation Award at Cardiostim 2014, the 19th World Congress in Cardiac Electrophysiology and Cardiac Techniques...

Report on Medical Device Market Outlines Challenges, Opportunities for Cost Containment

May 30, 2014 3:44 pm | by Rich Gedney, CEO, ADMET | Admet, Inc. | Blogs | Comments

The medical device market has experienced tremendous growth, reaching more than $330 billion worldwide. While the industry remains healthy, several challenges face those who design and manufacture medical devices. ADMET serves this market...

POST-IT Clinical Registry Demonstrates Importance of St. Jude Medical Fractional Flow Reserve Technology at EuroPCR 2014

May 22, 2014 2:28 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical Inc., a global medical device company, today announced results from the POST-IT (Portuguese Study on the Evaluation of FFR Guided Treatment of Coronary Disease) registry were presented during a hot line late-breaking clinical...

Preliminary Results from the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014 2:15 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical Inc., a global medical device company, today announced preliminary results from the EnligHTN III study, which found the company’s second-generation EnligHTN renal denervation system provided safe and effective therapy for...

Advertisement

St. Jude Medical Announces First Implants in US Study of the Portico Transcatheter Aortic Heart Valve System

May 14, 2014 8:50 am | by St. Jude Medical Inc. | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced that the first patient implants occurred in the Portico Re-sheathable Transcatheter Aortic Valve System U.S. IDE Trial (PORTICO trial). The trial is evaluating the Portico...

Leadless Pacemaker Showing Promising Results After One-Year

May 9, 2014 1:34 pm | by PR Newswire | News | Comments

Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising 12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional...

Pacemaker and Defibrillator Patients Adhering to Remote Monitoring with St. Jude Medical's Merlin Technology Saw More than Double Survival Rate

May 8, 2014 6:13 pm | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, announced that data presented during a Late Breaking Clinical Trial Session during Heart Rhythm 2014, the Heart Rhythm Society’s Annual Scientific Sessions, found an association between...

Scripps Is First in Region to Implant Wireless Cardiac Pacemaker

April 23, 2014 3:39 pm | by PR Newswire | News | Comments

Scripps Health became the first health care provider in Southern California to implant the investigational Nanostim™ leadless pacemaker, the world's first wireless pacemaker totally implanted in the heart, as part of the Leadless II Clinical...

Heart Device Lawsuits Continue Against St. Jude Over Defective Riata Lead Wires

April 18, 2014 2:38 pm | by The Associated Press | News | Comments

The Torkzadeh Law Firm (TorkLaw) is now representing over 100 clients against St. Jude Medical, Inc. related to the recalled St. Jude Medical, Inc. Riata leads. In November 2011, the FDA issued a Class 1 recall of the St. Jude Medical Riata...

First Patient in U.S. to Receive MRI Scan in Clinical Study of MRI-Compatible Pacemaker

April 10, 2014 8:36 pm | by PR Newswire | News | Comments

Providence Saint Joseph Medical Center is the first hospital in the nation to conduct an MRI scan of a patient implanted with a new MRI-compatible pacemaker – a breakthrough because metal implants often exclude patients from this imaging...

St. Jude Medical Recognized as Innovative Technology Supplier of the Year

April 9, 2014 12:19 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical, Inc., a global medical device company, was recognized by Novation as the 2013 Innovative Technology Supplier of the Year. Novation members selected the St Jude Medical ILUMIEN PCI Optimization System based on their experience...

World's First and Only Upgradeable Spinal Cord Stimulation System Receives FDA Approval

April 4, 2014 8:42 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the approval of its Protégé IPG from the U.S. Food and Drug Administration (FDA). Protégé is the first and only neurostimulation system that allows spinal cord stimulation...

Suit Charges St. Jude Riata Heart Lead Is a Defective Device

March 21, 2014 10:27 am | by Business Wire | News | Comments

Fabrice N. Vincent and Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, have announced that Robert Loiseau of Southampton, Pennsylvania, has filed a personal injury lawsuit against St. Jude...

European Launch of St. Jude's Spinal Cord Stimulation System with Burst Technology

March 20, 2014 8:31 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the CE Mark approval and European launch of its Prodigy Chronic Pain System with Burst Technology. As the first and only implantable neuromodulation system that delivers...

European Post-Approval Trial for St. Jude's Leadless Pacemaker Begins

March 18, 2014 8:26 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company’s LEADLESS Pacemaker Observational Study evaluating the Nanostim™ leadless pacing technology. The Nanostim pacemaker received CE...

Deep Brain Stimulation Devices Market for Parkinson's disease Expected to Reach USD 9.4 Billion Globally in 2019

March 18, 2014 7:28 am | by PR Newswire | News | Comments

According to a new market report published by Transparency Market Research "Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America)- Global Industry Analysis, Size, Share, Growth...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading